why choose us

Clinical Trials Search

Showing 14,470 of 132,963 result(s)
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Status: Completed

Condition: Growth Hormone Deficiency

Interventions: No intervention

Date: 2023-03-08

Daily Inclusion of Eggs in a Heart-Healthful Dietary Pattern in Hyperlipidemic Adults

Status: Completed

Condition: Hyperlipidemias

Interventions: Participants will receive guidance to follow a DASH dietary pattern tailored to their caloric requirements and their personal and cultural food prefer

Date: 2023-03-08

Health Outcomes of Parents With Cystic Fibrosis

Status: Completed

Condition: Cystic Fibrosis

Interventions: The aim of the study is to assess the impact parenthood has on health outcomes.

Date: 2023-03-08

In Line Aerosol Nebulization With High Flow

Status: Completed

Condition: Hypoxemic Respiratory Failure

Interventions: nebulized delivery of bronchodilator via in-line drug delivery maintaining high-flow nasal cannula oxygen

Date: 2023-03-08

Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring

Status: Completed

Condition: Kidney Diseases

Interventions: 130 mg administered by intravenous injection over 30-60 seconds, followed by a 10 mL normal saline flush administered intravenously over 30-60 seconds

Date: 2023-03-08

Radicle Health1: A Study of Health and Wellness Formulations and Their Effects on Overall Health

Status: COMPLETED

Condition: Sleep

Interventions: Participants will use their Placebo Control Form 1 Capsules as directed for a period of 4 weeks.

Date: 2023-03-08

Quality of Recovery From Mastectomy With and Without PECS Blocks

Status: Completed

Condition: Post Operative Pain

Interventions: Approximately half of patients recruited will receive a PECS block with Liposomal bupivacaine and half will not receive a block.

Date: 2023-03-08

18F-LY3950321-01 Biodistribution and Safety Study

Status: COMPLETED

Condition: Diagnostic Agent Adverse Reaction

Interventions: 3 millicuries (±1 mCi)

Date: 2023-03-08

MCW Alpha;Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

Status: Completed

Condition: Leukemia

Interventions: Participants in this study will receive a blood stem cell transplant, which will use an investigational device called the CliniMACs device to remove a

Date: 2023-03-08

Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

Status: Completed

Condition: Pancreatic Cancer

Interventions: 125 mg;m2 weekly, on days 1,8, and 15 or on days 1 and 15 as a 30-40 minute infusion administered first

Date: 2023-03-08